HemaTrack-ALL is an innovative NGS-based, end-to-end workflow which features the identification of markers of ALL blasts and their subsequent high sensitivity quantitative tracking. The assay presents with a straightforward way of quantification, meets the clinical requirements in terms of accuracy and sensitivity and will be further evaluated in real-live clinical routine in a prospective clinical trial in India next year.